Einfluss des Lebensstils auf neurodegenerative Erkrankungen

作者: J.B. Schulz , G. Deuschl

DOI: 10.1007/S00115-014-4252-Y

关键词: Internal medicinePsychosomatic medicineIncidence (epidemiology)DiseaseNeurologyPsychopharmacologyMediterranean dietNeurosurgeryMedicineDementia

摘要: Lifestyle factors in midlife have an important influence on the risk of developing a neurodegenerative disease during later life. Data lifestyle exist for Alzheimer's and Parkinson's disease. Continuous physical cognitive activity, balanced or Mediterranean diet with high proportion unsaturated fatty acids, pharmacological treatment arterial hypertension, sufficient unfragmented sleep possibly lipophilic statins reduce dementia Several studies recent years provided evidence that last decades age-adjusted incidence has decreased. This is probably due to healthier factors. activity also decreases likelihood Whether course progression diseases symptomatic stages unknown.

参考文章(27)
Michelle W. Voss, Carmen Vivar, Arthur F. Kramer, Henriette van Praag, Bridging animal and human models of exercise-induced brain plasticity. Trends in Cognitive Sciences. ,vol. 17, pp. 525- 544 ,(2013) , 10.1016/J.TICS.2013.08.001
Kenneth M. Langa, Eric B. Larson, Jason H. Karlawish, David M. Cutler, Mohammed U. Kabeto, Scott Y. Kim, Allison B. Rosen, Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity? Alzheimer's & Dementia. ,vol. 4, pp. ALZJJALZ200801001- 144 ,(2008) , 10.1016/J.JALZ.2008.01.001
Miriam Reiner, Christina Niermann, Darko Jekauc, Alexander Woll, Long-term health benefits of physical activity – a systematic review of longitudinal studies BMC Public Health. ,vol. 13, pp. 813- 813 ,(2013) , 10.1186/1471-2458-13-813
Prashanthi Vemuri, Timothy G. Lesnick, Scott A. Przybelski, David S. Knopman, Rosebud O. Roberts, Val J. Lowe, Kejal Kantarci, Mathew L. Senjem, Jeffrey L. Gunter, Bradley F. Boeve, Ronald C. Petersen, Clifford R. Jack, Effect of lifestyle activities on Alzheimer disease biomarkers and cognition. Annals of Neurology. ,vol. 72, pp. 730- 738 ,(2012) , 10.1002/ANA.23665
G. Li, E. B. Larson, J. A. Sonnen, J. B. Shofer, E. C. Petrie, A. Schantz, E. R. Peskind, M. A. Raskind, J.C.S. Breitner, T. J. Montine, Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease Neurology. ,vol. 69, pp. 878- 885 ,(2008) , 10.1212/01.WNL.0000277657.95487.1C
Elizabeth A. Hahn, Hui-Xin Wang, Ross Andel, Laura Fratiglioni, A Change in Sleep Pattern May Predict Alzheimer Disease The American Journal of Geriatric Psychiatry. ,vol. 22, pp. 1262- 1271 ,(2014) , 10.1016/J.JAGP.2013.04.015
J.-E. Kang, M. M. Lim, R. J. Bateman, J. J. Lee, L. P. Smyth, J. R. Cirrito, N. Fujiki, S. Nishino, D. M. Holtzman, Amyloid-β Dynamics are Regulated by Orexin and the Sleep-Wake Cycle Science. ,vol. 326, pp. 1005- 1007 ,(2009) , 10.1126/SCIENCE.1180962
HH Feldman, RS Doody, Miia Kivipelto, DL Sparks, DD Waters, RW Jones, E Schwam, R Schindler, J Hey-Hadavi, DA DeMicco, A Breazna, None, Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe Neurology. ,vol. 74, pp. 956- 964 ,(2010) , 10.1212/WNL.0B013E3181D6476A
Benjamin Wolozin, Wendy Kellman, Paul Ruosseau, Gastone G Celesia, George Siegel, Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. JAMA Neurology. ,vol. 57, pp. 1439- 1443 ,(2000) , 10.1001/ARCHNEUR.57.10.1439
Robert D. Abbott, Walking and Dementia in Physically Capable Elderly Men JAMA. ,vol. 292, pp. 1447- 1453 ,(2004) , 10.1001/JAMA.292.12.1447